BACKGROUND: In Asia, breast cancer is characterised by an early age of onset: In Malaysia, approximately 50% of cases occur in women under the age of 50 years. A proportion of these cases may be attributable, at least in part, to genetic components, but to date, the contribution of genetic components to breast cancer in many of Malaysia's ethnic groups has not been well-characterised. METHODOLOGY: Given that hereditary breast carcinoma is primarily due to germline mutations in one of two breast cancer susceptibility genes, BRCA1 and BRCA2, we have characterised the spectrum of BRCA mutations in a cohort of 37 individuals with early-onset disease (<or=40 years) and no reported family history. Mutational analysis of BRCA1 and BRCA2 was conduc...
Breast cancer is a major health problem in Indonesia, especially among young women. Early onset brea...
Background: The partner and localizer of breast cancer 2 (PALB2) is responsible for facilitating BRC...
Women who carry a pathogenic mutation in the breast cancer susceptibility genes BRCA1 or BRCA2 (BRCA...
In Asia, breast cancer is characterised by an early age of onset: In Malaysia, approximately 50% of ...
<p><strong>Background:</strong> To ascertain the contribution of germline alterations in <em>BRCA1</...
BACKGROUND: Genetic testing for BRCA1 and BRCA2 is offered typically to selected women based on age ...
Background Genetic testing for BRCA1 and BRCA2 is offered typically to selected women based on age o...
Thirty patients with early onset breast cancer or familial breast cancer from Malaysia were analysed...
Age-adjusted incidence rates of breast cancer vary more than 10-fold worldwide, with the highest rat...
Breast cancer among women has reached an alarming stage compared to 20 years ago. It was found that ...
Insight GBCC II : Asian Hereditary Breast CancerThe prevalence of breast cancer in Asians is lower t...
found in most families with cases of both breast and ovarian cancer or with many cases of early-onse...
Early studies of genetic predisposition due to the BRCA1 and BRCA2 genes have focused largely on seq...
BACKGROUND: Little is known about the frequency and spectrum of BRCA 1/2 mutations among Chinese pop...
The data related to BRCA1 germline mutation in Chinese women with familial breast cancer is increasi...
Breast cancer is a major health problem in Indonesia, especially among young women. Early onset brea...
Background: The partner and localizer of breast cancer 2 (PALB2) is responsible for facilitating BRC...
Women who carry a pathogenic mutation in the breast cancer susceptibility genes BRCA1 or BRCA2 (BRCA...
In Asia, breast cancer is characterised by an early age of onset: In Malaysia, approximately 50% of ...
<p><strong>Background:</strong> To ascertain the contribution of germline alterations in <em>BRCA1</...
BACKGROUND: Genetic testing for BRCA1 and BRCA2 is offered typically to selected women based on age ...
Background Genetic testing for BRCA1 and BRCA2 is offered typically to selected women based on age o...
Thirty patients with early onset breast cancer or familial breast cancer from Malaysia were analysed...
Age-adjusted incidence rates of breast cancer vary more than 10-fold worldwide, with the highest rat...
Breast cancer among women has reached an alarming stage compared to 20 years ago. It was found that ...
Insight GBCC II : Asian Hereditary Breast CancerThe prevalence of breast cancer in Asians is lower t...
found in most families with cases of both breast and ovarian cancer or with many cases of early-onse...
Early studies of genetic predisposition due to the BRCA1 and BRCA2 genes have focused largely on seq...
BACKGROUND: Little is known about the frequency and spectrum of BRCA 1/2 mutations among Chinese pop...
The data related to BRCA1 germline mutation in Chinese women with familial breast cancer is increasi...
Breast cancer is a major health problem in Indonesia, especially among young women. Early onset brea...
Background: The partner and localizer of breast cancer 2 (PALB2) is responsible for facilitating BRC...
Women who carry a pathogenic mutation in the breast cancer susceptibility genes BRCA1 or BRCA2 (BRCA...